EconPapers    
Economics at your fingertips  
 

The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation

Jeniffer B. Hernandez, Christina Chang, Mathias LeBlanc, David Grimm, John Le Lay, Klaus H. Kaestner, Ye Zheng and Marc Montminy ()
Additional contact information
Jeniffer B. Hernandez: Peptide Biology Laboratories, Salk Institute
Christina Chang: Nomis Foundation for Immunobiology and Microbial Pathogenesis Laboratories, Salk Institute
Mathias LeBlanc: Peptide Biology Laboratories, Salk Institute
David Grimm: Peptide Biology Laboratories, Salk Institute
John Le Lay: Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine
Klaus H. Kaestner: Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine
Ye Zheng: Nomis Foundation for Immunobiology and Microbial Pathogenesis Laboratories, Salk Institute
Marc Montminy: Peptide Biology Laboratories, Salk Institute

Nature Communications, 2015, vol. 6, issue 1, 1-9

Abstract: Abstract Following their activation in response to inflammatory signals, innate immune cells secrete T-cell-polarizing cytokines that promote the differentiation of naive CD4 T cells into T helper (Th) cell subsets. Among these, Th17 cells play a prominent role in the development of a number of autoimmune diseases. Although regarded primarily as an immunosuppressant signal, cAMP has been found to mediate pro-inflammatory effects of macrophage-derived prostaglandin E2 (PGE2) on Th17 cells. Here we show that PGE2 enhances Th17 cell differentiation via the activation of the CREB co-activator CRTC2. Following its dephosphorylation, CRTC2 stimulates the expression of the cytokines IL-17A and IL-17F by binding to CREB over both promoters. CRTC2-mutant mice have decreased Th17 cell numbers, and they are protected from experimental autoimmune encephalitis, a model for multiple sclerosis. Our results suggest that small molecule inhibitors of CRTC2 may provide therapeutic benefit to individuals with autoimmune disease.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms8216 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8216

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms8216

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8216